The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients

Tomomi Morikawa, Takayuki Manabe, Yoshihito Ito, Shinnosuke Yamada, Akira Yoshimi, Taku Nagai, Norio Ozaki, Akira Maeda

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The high-mobility group A protein 1a (HMGA1a) is a well-documented DNA-binding protein acting as an architectural transcription regulator. Recently, HMGA1a protein has been identified as a hypoxia-inducible RNA-binding trans-acting factor for aberrant splicing of presenilin-2 (PS2) pre-mRNA observed in the brains of sporadic Alzheimer's disease. Interestingly, this aberrant splicing of PS2 was also observed in the brains of bipolar disorder and schizophrenia. Many downstream genes under the control of HMGA1a could be associated with schizophrenia. On the other hand, many gene transcripts are aberrantly spliced in schizophrenia. Therefore, we examined the expression at the mRNA and protein levels of this DNA- and RNA-binding factor HMGA1a in the lymphoblastoid cell lines obtained from 16 schizophrenia patients with age-matched controls. We observed markedly higher HMGA1a mRNA and the increased HMGA1a protein in the nuclear fractions of schizophrenia patients. In contrast, there were no significant differences in the expression levels of HMGA1b, which is an alternatively spliced isoform of HMGA1a. The present study is the first to report a significant upregulation of HMGA1a in schizophrenia, suggesting its potential roles in both transcription and splicing of target genes linked with schizophrenia.

Original languageEnglish
Pages (from-to)736-739
Number of pages4
JournalNeurochemistry International
Volume56
Issue number6-7
DOIs
Publication statusPublished - 01-05-2010

Fingerprint

High Mobility Group Proteins
Schizophrenia
Cell Line
Presenilin-2
RNA
Genes
Messenger RNA
Trans-Activators
RNA Precursors
DNA-Binding Proteins
Brain Diseases
Nuclear Proteins
Bipolar Disorder
Alzheimer Disease
Protein Isoforms
Proteins
Up-Regulation
DNA

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Morikawa, Tomomi ; Manabe, Takayuki ; Ito, Yoshihito ; Yamada, Shinnosuke ; Yoshimi, Akira ; Nagai, Taku ; Ozaki, Norio ; Maeda, Akira. / The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients. In: Neurochemistry International. 2010 ; Vol. 56, No. 6-7. pp. 736-739.
@article{d1027a50d68b4becbef795e97e9e76cd,
title = "The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients",
abstract = "The high-mobility group A protein 1a (HMGA1a) is a well-documented DNA-binding protein acting as an architectural transcription regulator. Recently, HMGA1a protein has been identified as a hypoxia-inducible RNA-binding trans-acting factor for aberrant splicing of presenilin-2 (PS2) pre-mRNA observed in the brains of sporadic Alzheimer's disease. Interestingly, this aberrant splicing of PS2 was also observed in the brains of bipolar disorder and schizophrenia. Many downstream genes under the control of HMGA1a could be associated with schizophrenia. On the other hand, many gene transcripts are aberrantly spliced in schizophrenia. Therefore, we examined the expression at the mRNA and protein levels of this DNA- and RNA-binding factor HMGA1a in the lymphoblastoid cell lines obtained from 16 schizophrenia patients with age-matched controls. We observed markedly higher HMGA1a mRNA and the increased HMGA1a protein in the nuclear fractions of schizophrenia patients. In contrast, there were no significant differences in the expression levels of HMGA1b, which is an alternatively spliced isoform of HMGA1a. The present study is the first to report a significant upregulation of HMGA1a in schizophrenia, suggesting its potential roles in both transcription and splicing of target genes linked with schizophrenia.",
author = "Tomomi Morikawa and Takayuki Manabe and Yoshihito Ito and Shinnosuke Yamada and Akira Yoshimi and Taku Nagai and Norio Ozaki and Akira Maeda",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.neuint.2010.03.011",
language = "English",
volume = "56",
pages = "736--739",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "6-7",

}

The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients. / Morikawa, Tomomi; Manabe, Takayuki; Ito, Yoshihito; Yamada, Shinnosuke; Yoshimi, Akira; Nagai, Taku; Ozaki, Norio; Maeda, Akira.

In: Neurochemistry International, Vol. 56, No. 6-7, 01.05.2010, p. 736-739.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients

AU - Morikawa, Tomomi

AU - Manabe, Takayuki

AU - Ito, Yoshihito

AU - Yamada, Shinnosuke

AU - Yoshimi, Akira

AU - Nagai, Taku

AU - Ozaki, Norio

AU - Maeda, Akira

PY - 2010/5/1

Y1 - 2010/5/1

N2 - The high-mobility group A protein 1a (HMGA1a) is a well-documented DNA-binding protein acting as an architectural transcription regulator. Recently, HMGA1a protein has been identified as a hypoxia-inducible RNA-binding trans-acting factor for aberrant splicing of presenilin-2 (PS2) pre-mRNA observed in the brains of sporadic Alzheimer's disease. Interestingly, this aberrant splicing of PS2 was also observed in the brains of bipolar disorder and schizophrenia. Many downstream genes under the control of HMGA1a could be associated with schizophrenia. On the other hand, many gene transcripts are aberrantly spliced in schizophrenia. Therefore, we examined the expression at the mRNA and protein levels of this DNA- and RNA-binding factor HMGA1a in the lymphoblastoid cell lines obtained from 16 schizophrenia patients with age-matched controls. We observed markedly higher HMGA1a mRNA and the increased HMGA1a protein in the nuclear fractions of schizophrenia patients. In contrast, there were no significant differences in the expression levels of HMGA1b, which is an alternatively spliced isoform of HMGA1a. The present study is the first to report a significant upregulation of HMGA1a in schizophrenia, suggesting its potential roles in both transcription and splicing of target genes linked with schizophrenia.

AB - The high-mobility group A protein 1a (HMGA1a) is a well-documented DNA-binding protein acting as an architectural transcription regulator. Recently, HMGA1a protein has been identified as a hypoxia-inducible RNA-binding trans-acting factor for aberrant splicing of presenilin-2 (PS2) pre-mRNA observed in the brains of sporadic Alzheimer's disease. Interestingly, this aberrant splicing of PS2 was also observed in the brains of bipolar disorder and schizophrenia. Many downstream genes under the control of HMGA1a could be associated with schizophrenia. On the other hand, many gene transcripts are aberrantly spliced in schizophrenia. Therefore, we examined the expression at the mRNA and protein levels of this DNA- and RNA-binding factor HMGA1a in the lymphoblastoid cell lines obtained from 16 schizophrenia patients with age-matched controls. We observed markedly higher HMGA1a mRNA and the increased HMGA1a protein in the nuclear fractions of schizophrenia patients. In contrast, there were no significant differences in the expression levels of HMGA1b, which is an alternatively spliced isoform of HMGA1a. The present study is the first to report a significant upregulation of HMGA1a in schizophrenia, suggesting its potential roles in both transcription and splicing of target genes linked with schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=77952292585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952292585&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2010.03.011

DO - 10.1016/j.neuint.2010.03.011

M3 - Article

C2 - 20347905

AN - SCOPUS:77952292585

VL - 56

SP - 736

EP - 739

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 6-7

ER -